{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:56:19Z","timestamp":1774968979865,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX001532"],"award-info":[{"award-number":["BX001532"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188438","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T18:30:32Z","timestamp":1512498632000},"page":"e0188438","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Restoration of the prolyl-hydroxylase domain protein-3 oxygen-sensing mechanism is responsible for regulation of HIF2\u03b1 expression and induction of sensitivity of myeloma cells to hypoxia-mediated apoptosis"],"prefix":"10.1371","volume":"12","author":[{"given":"Gilberto","family":"Gastelum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Poteshkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mysore","family":"Veena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Artiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine","family":"Weckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3348-5983","authenticated-orcid":true,"given":"Patrick","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/emboj.2012.125","article-title":"The updated biology of hypoxia-inducible factor","volume":"31","author":"SN Greer","year":"2012","journal-title":"Embo J"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cardiores.2006.05.005","article-title":"Regulating cellular oxygen sensing by hydroxylation","volume":"71","author":"J Fandrey","year":"2006","journal-title":"Cardiovascular research"},{"issue":"22","key":"ref3","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"H Zhong","year":"1999","journal-title":"Cancer Res"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"GL Semenza","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"ref5","first-page":"13","article-title":"Prolyl-hydroxylase 3: Evolving Roles for an Ancient Signaling Protein","volume":"2013","author":"TL Place","year":"2013","journal-title":"Hypoxia (Auckl)"},{"issue":"6","key":"ref6","first-page":"810","article-title":"Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression","volume":"90","author":"K Asosingh","year":"2005","journal-title":"Haematologica"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-14-3400","article-title":"Metabolic signature identifies novel targets for drug resistance in multiple myeloma","volume":"75","author":"P Maiso","year":"2015","journal-title":"Cancer Res"},{"key":"ref8","article-title":"An HRE-binding Py-Im polyamide impairs hypoxic signaling in tumors","author":"JO Szablowski","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1541-7786.MCR-15-0361","article-title":"A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity","volume":"14","author":"VS Mysore","year":"2016","journal-title":"Molecular cancer research: MCR"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","article-title":"Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer","volume":"8","author":"S Lee","year":"2005","journal-title":"Cancer Cell"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"e40053","DOI":"10.1371\/journal.pone.0040053","article-title":"Suppression of glioma progression by Egln3","volume":"7","author":"VA Sciorra","year":"2012","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/ncomms6582","article-title":"Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR","volume":"5","author":"AT Henze","year":"2014","journal-title":"Nat Commun"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1158\/0008-5472.CAN-15-1474","article-title":"Prolyl Hydroxylase 3 Attenuates MCL-1-Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells","volume":"76","author":"P Radhakrishnan","year":"2016","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1038\/ncomms10539","article-title":"Epigenetic re-expression of HIF-2alpha suppresses soft tissue sarcoma growth","volume":"7","author":"MS Nakazawa","year":"2016","journal-title":"Nat Commun"},{"issue":"31","key":"ref15","doi-asserted-by":"crossref","first-page":"31721","DOI":"10.18632\/oncotarget.5564","article-title":"Distinct breast cancer stem\/progenitor cell populations require either HIF1 alpha or loss of PHD3 to expand under hypoxic conditions","volume":"6","author":"O Iriondo","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/sj.bjc.6605936","article-title":"PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer","volume":"103","author":"Y Su","year":"2010","journal-title":"Br J Cancer"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"e14617","DOI":"10.1371\/journal.pone.0014617","article-title":"Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells","volume":"6","author":"TL Place","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"635a","DOI":"10.1182\/blood.V110.11.2132.2132","article-title":"Epigenetic profiling identifies EGLN3 as a frequent target for transcriptional silencing in plasma cell neoplasias","volume":"110","author":"R Shah","year":"2007","journal-title":"Blood"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0609.2009.01344.x","article-title":"The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia","volume":"84","author":"E Hatzimichael","year":"2010","journal-title":"Eur J Haematol"},{"issue":"13","key":"ref20","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1182\/blood-2004-03-1153","article-title":"In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model","volume":"104","author":"P Frost","year":"2004","journal-title":"Blood"},{"issue":"16","key":"ref21","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"E Berra","year":"2003","journal-title":"EMBO J"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1128\/MCB.02041-07","article-title":"Abnormal sympathoadrenal development and systemic hypotension in PHD3-\/- mice","volume":"28","author":"T Bishop","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/1535-7163.MCT-13-0123","article-title":"Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro","volume":"12","author":"J Hu","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1535-7163.MCT-09-0150","article-title":"Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan","volume":"8","author":"Y Hu","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"897025","DOI":"10.1155\/2013\/897025","article-title":"Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis","volume":"2013","author":"P Frost","year":"2013","journal-title":"J Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/sj.onc.1210019","article-title":"AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells","volume":"26","author":"P Frost","year":"2007","journal-title":"Oncogene"},{"issue":"23","key":"ref27","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"J Brugarolas","year":"2004","journal-title":"Genes Dev"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-05-0068","article-title":"Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor\/insulin receptor substrate-1\/phosphatidylinositol 3-kinase cascade","volume":"4","author":"Y Shi","year":"2005","journal-title":"Mol Cancer Ther"},{"issue":"24","key":"ref29","first-page":"8777","article-title":"Expression of prolyl-hydroxylase-1 (PHD1\/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth","volume":"63","author":"N Erez","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/ijc.21488","article-title":"Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1","volume":"118","author":"H Kato","year":"2006","journal-title":"Int J Cancer"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.gastro.2009.09.049","article-title":"Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity","volume":"138","author":"J Xue","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood-2006-10-052845","article-title":"JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells","volume":"110","author":"T Kiziltepe","year":"2007","journal-title":"Blood"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3324\/haematol.12261","article-title":"The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma","volume":"93","author":"T Khong","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1158\/1535-7163.MCT-08-0254","article-title":"Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin","volume":"8","author":"P Frost","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"ref35","first-page":"3111","article-title":"Prognostic value of bone marrow angiogenesis in multiple myeloma","volume":"6","author":"SV Rajkumar","year":"2000","journal-title":"Clin Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T20:49:55Z","timestamp":1603486195000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188438"}},"subtitle":[],"editor":[{"given":"Nicola","family":"Amodio","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188438","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]}}}